![]() ![]() ![]() The editorial acknowledges the difficulties that all countries face in coping with the coronavirus. But this election gives us the power to render judgment." "Our leaders have largely claimed immunity for their actions. "Anyone else who recklessly squandered lives and money in this way would be suffering legal consequences," the editorial states. leaders have denigrated experts and ceded disease control to the states, the journal's editors say. has recorded more than 212,000 deaths from the coronavirus - the most in the world. has distinct advantages in biomedical research, manufacturing capacity and public health expertise compared with many other countries, the U.S. "There have been many mistakes made that were not only foolish but reckless," Rubin tells CNN, "and I think we want people to realize that there are truths here, not just opinions."Įven though the U.S. Eric Rubin says the editorial is rare for two main reasons: It's one of the handful of times an editorial has been signed by all the editors, and it takes an unprecedented political stand. The New England Journal of Medicine is at least the third widely respected medical or science journal to call for a change in U.S. "Instead of relying on expertise, the administration has turned to uninformed 'opinion leaders' and charlatans who obscure the truth and facilitate the promulgation of outright lies," the editorial states. But it refers to the Trump administration repeatedly, and its footnotes cite news articles about Trump insisting that coronavirus risks are overblown, pressuring federal scientists, and politicizing the search for treatments. The piece, titled "Dying in a Leadership Vacuum" and published Wednesday, does not mention President Trump or his Democratic rival, Joe Biden, by name. The editors accuse Trump's government of a massive public health failure - and of worsening the pandemic's effects by prioritizing politics over sound medical guidance. "We should not abet them and enable the deaths of thousands more Americans by allowing them to keep their jobs." "When it comes to the response to the largest public health crisis of our time, our current political leaders have demonstrated that they are dangerously incompetent," reads the editorial signed by nearly three dozen of the journal's editors. presidential election since it was founded in 1812. It is the first time the prestigious medical journal has taken a stance on a U.S. The Trump administration has "taken a crisis and turned it into a tragedy" in its response to the COVID-19 pandemic, The New England Journal of Medicine says in a scathing editorial that essentially calls on American voters to throw the president out of office. But this election gives us the power to render judgment," reads a New England Journal of Medicine editorial signed by some three dozen editors. “I did not do enough to ensure that the data source was appropriate for this use,” Mehra said in a statement apologizing for the “disruptions” the papers caused."Our leaders have largely claimed immunity for their actions. Surgisphere declined to release the full dataset to independent peer reviewers because a transfer “would violate client agreements and confidentiality requirement,” according to the retraction statement in the Lancet. In both cases, the problems related to the use of a database provided by Surgisphere Corp. The Lancet paper received a great deal of attention because it found no benefit in the use of hydroxychloroquine or chloroquine to treat COVID-19. The Lancet also retracted a paper from the same lead author, Mandeep R. The study’s authors wrote that the retraction was necessary, stating that “because all the authors were not granted access to the raw data and the raw data could not be made available to a third-party auditor, we are unable to validate the primary data sources underlying our article.” The retraction of this one article does not materially affect the KN article’s conclusion citing an expert consensus that patients on blood pressure medications that block the renin-angiotensin system should continue taking these drugs during the COVID-19 pandemic unless otherwise instructed by a physician. That study found that neither ACE inhibitors nor ARBs were associated with an increased risk of in-hospital death.” The Kidney News article described this retracted article as “a database study of 8910 patients who had been hospitalized in 11 countries on three continents. The New England Journal of Medicine has retracted one of the articles cited in the June Kidney News article, “Evidence Mounts that RAS-Blocking Medications Pose No Danger to COVID-19.” ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |